Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jupiter Neurosciences (JUNS) Return on Equity (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Return on Equity for 2 consecutive years, with 10.08% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 585.0% to 10.08% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 10.08% through Dec 2025, up 585.0% year-over-year, with the annual reading at 7.67% for FY2025, N/A changed from the prior year.
  • Return on Equity for Q4 2025 was 10.08% at Jupiter Neurosciences, up from 10.81% in the prior quarter.
  • The five-year high for Return on Equity was 10.08% in Q4 2025, with the low at 10.81% in Q3 2025.